Daiichi Sankyo Patents – Insights & Stats

Daiichi Sankyo has a total of 13657 patents globally, out of which 5518 have been granted. Of these 13657 patents, more than 41% patents are active. Japan is where Daiichi Sankyo has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, Japan seems to be the main focused R&D centre and United States of America is the origin country of Daiichi Sankyo.

Daiichi Sankyo was founded in the year 1899. The Company offers pharmaceutical products. The Company provides medicines for high and low blood pressure, heart related events and other related diseases. Daiichi Sankyo serves customers worldwide.

Do read about some of the most popular patents of Daiichi Sankyo which have been covered by us in this article and also you can find Daiichi Sankyo patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Daiichi Sankyo patent portfolio.

How many patents does the founder and the CEO of Daiichi Sankyo have?

The founder Takamine Jokichi has 0 patent and CEO Daiichi Sankyo has 0 patent.

How many patents does Daiichi Sankyo have?

Daiichi Sankyo has a total of 13657 patents globally. These patents belong to 3123 unique patent families. Out of 13657 patents, 5679 patents are active.

How Many Patents did Daiichi Sankyo File Every Year?

Daiichi Sankyo Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantDaiichi Sankyo Applications FiledDaiichi Sankyo Patents Granted
2023653
2022110272
2021321312
2020379316
2019551317
2018499415
2017505458
2016604434
2015612370
2014668352
2013798258
2012610148

Which Daiichi Sankyo Drug Patents are Expiring in the Next 10 Years?

The patent no. US8557810B2 which is expiring in Mar, 2027, describing a modulator is a substance that can influence the activity of enzymes like kinases, which play a role in treating, preventing, or alleviating diseases related to enzyme activity or symptoms. This modulator works by attaching to the specific kinase of interest, rather than non-preferred kinases.

Given below is the list of few drugs patented by Daiichi Sankyo accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.

Drug NamePatent NumberPatent TitlePatent Expiration
VanflytaUS8557810B2Imidazolothiazole Compounds For The…Mar, 2027
TuralioUS10730876B2Synthesis of a Compound That…May, 2036
SavaysaUS9149532B2Pharmaceutical CompositionMar, 2028

How many Daiichi Sankyo patents are Alive/Dead?

Daiichi Sankyo Patent Portfolio

How Many Patents did Daiichi Sankyo File in Different Countries?

Daiichi Sankyo Worldwide Patent Filing

Top 30 Countries in which Daiichi Sankyo Filed Patents

CountryPatents
Japan1866
United States Of America1229
Europe930
China640
Taiwan617
Korea (South)610
Canada523
Germany487
Australia483
Hong Kong (S.A.R.)461
Israel370
India369
Brazil363
Spain346
Singapore284
Mexico250
Russia246
South Africa185
Norway184
Indonesia183
Austria168
Denmark165
Malaysia156
New Zealand151
Viet Nam150
Philippines145
Portugal116
Colombia94
Hungary93
Poland90

Where are Research Centres of Daiichi Sankyo Patents Located?

R&D Centers of Daiichi Sankyo

 10 Best Daiichi Sankyo Patents

WO2007007757A1 is the most popular patent in the Daiichi Sankyo portfolio. It has received 650 citations so far from companies like Nitto Denko Corporation and Tsujimoto Chemical Industry.

Below is the list of 10 most cited patents of Daiichi Sankyo:

Publication NumberCitation Count
WO2007007757A1650
WO2007004705A1612
WO2003016326A1317
WO2009020093A1280
US20050171172A1254
WO2008079909A1229
US7449134B2223
WO2004060364A1221
WO2008099944A1219
WO2003024913A1212

How many inventions of other companies were rejected due to Daiichi Sankyo patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Daiichi Sankyo invention. They couldn’t because Daiichi Sankyo had protected those before them.

Examiners at the USPTO referred 199 Daiichi Sankyo patents in 773 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Daiichi Sankyo patent portfolio are Plexxikon, Ambit Biosciences and Roche Holding.

List of the Companies whose Patents were rejected citing Daiichi Sankyo –

CompanyNumber of Patent Applications that faced Rejection Citing Daiichi Sankyo PatentsNumber of Rejections (102 & 103)
Plexxikon1442
Ambit Biosciences920
Roche Holding921
Novartis616
National Institutes Of Health622
American Regent511
Gilead Pharmasset58
Sarepta Therapeutics511
Omeros Corporation411
Osaka University44

Count of 102 and 103 Type Rejections based on Daiichi Sankyo Patents

Top Daiichi Sankyo Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20100249118A111
US20070082861A110
US7754702B210
US7705130B29
US20100310659A17
US20090076046A17
US20100317659A17
US20090131413A16
US6693115B25
US7585859B25
US20090017024A15
US6960571B25
US20100286178A14
US20100209490A14
US20050153989A14

What Percentage of Daiichi Sankyo US Patent Applications were Granted?

Daiichi Sankyo (Excluding its subsidiaries) has filed 716 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 461 have been granted leading to a grant rate of 72.83%.

Below are the key stats of Daiichi Sankyo patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Daiichi Sankyo?

Law FirmTotal ApplicationsSuccess Rate
Christensen O Connor Johnson Kindness12079.57%
Foley & Lardner9476.56%
Holtz Holtz & Volek7757.14%
Daiichi Sankyo Company6283.05%
Locke Lord5446.30%
Oblon Mcclelland Maier & Neustadt4173.17%
Faegre Drinker Biddle & Reath2575.00%
Plexxikon21100.00%
Hunton Andrews Kurth2070.00%
Cooley1792.86%

What are Daiichi Sankyo key innovation segments?

What Technologies are Covered by Daiichi Sankyo?

The chart below distributes patents filed by Daiichi Sankyo in different countries on the basis of the technology protected in patents. It also represents the markets where Daiichi Sankyo thinks it’s important to protect particular technology inventions.

R&D Focus: How has Daiichi Sankyo search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Daiichi Sankyo?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.